Cochrane Abstracts
Rivastigmine for dementia in people with Down syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rivastigmine for Dementia in People With Down Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435338/all/Rivastigmine_for_dementia_in_people_with_Down_syndrome.
Rivastigmine for dementia in people with Down syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435338/all/Rivastigmine_for_dementia_in_people_with_Down_syndrome. Accessed January 20, 2025.
Rivastigmine for dementia in people with Down syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435338/all/Rivastigmine_for_dementia_in_people_with_Down_syndrome
Rivastigmine for Dementia in People With Down Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435338/all/Rivastigmine_for_dementia_in_people_with_Down_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rivastigmine for dementia in people with Down syndrome
ID - 435338
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435338/all/Rivastigmine_for_dementia_in_people_with_Down_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
